ES531585A0 - Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina - Google Patents

Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina

Info

Publication number
ES531585A0
ES531585A0 ES531585A ES531585A ES531585A0 ES 531585 A0 ES531585 A0 ES 531585A0 ES 531585 A ES531585 A ES 531585A ES 531585 A ES531585 A ES 531585A ES 531585 A0 ES531585 A0 ES 531585A0
Authority
ES
Spain
Prior art keywords
leu
glu
ala
gln
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531585A
Other languages
English (en)
Other versions
ES8606406A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of ES531585A0 publication Critical patent/ES531585A0/es
Publication of ES8606406A1 publication Critical patent/ES8606406A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Control Of Eletrric Generators (AREA)
  • Vehicle Body Suspensions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Bipolar Transistors (AREA)
ES531585A 1983-04-14 1984-04-13 Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina Expired ES8606406A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/484,931 US4489163A (en) 1983-04-14 1983-04-14 rCRF and analogs

Publications (2)

Publication Number Publication Date
ES531585A0 true ES531585A0 (es) 1986-04-01
ES8606406A1 ES8606406A1 (es) 1986-04-01

Family

ID=23926236

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531585A Expired ES8606406A1 (es) 1983-04-14 1984-04-13 Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina

Country Status (16)

Country Link
US (1) US4489163A (es)
EP (1) EP0122798B1 (es)
JP (1) JPH0689034B2 (es)
KR (1) KR900006559B1 (es)
AT (1) ATE96807T1 (es)
AU (1) AU565699B2 (es)
CA (1) CA1247602A (es)
DE (1) DE3486238T2 (es)
DK (1) DK172682B1 (es)
ES (1) ES8606406A1 (es)
GR (1) GR81467B (es)
IE (1) IE61617B1 (es)
IL (1) IL71326A (es)
NZ (1) NZ207779A (es)
PH (1) PH23123A (es)
ZA (1) ZA842460B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE88481T1 (de) * 1984-02-23 1993-05-15 Salk Inst For Biological Studi Crf-analoga.
FR2567524B1 (fr) * 1984-07-10 1987-11-27 Sanofi Sa Procede de synthese de la somatocrinine en phase liquide et peptides intermediaires
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
DE3703340A1 (de) * 1987-02-04 1988-08-18 Dirck Dr Med Oppermann Pharmazeutische zubereitung zur behandlung der herzinsuffizienz
CA1341051C (en) * 1988-09-23 2000-07-11 Jean Edouard Frederic Rivier Crf antagonists
CA1340964C (en) * 1988-09-30 2000-04-18 Jean E. F. Rivier Crf analogs
US5278146A (en) * 1988-09-30 1994-01-11 The Salk Institute For Biological Studies CRF analogs
ZA898329B (en) * 1988-11-14 1990-07-25 Salk Inst For Biological Studi Fish crf
US5137871A (en) * 1989-07-28 1992-08-11 Regents Of The University Of California Treatment to reduce edema for brain and musculature injuries
US5488033A (en) * 1989-07-28 1996-01-30 The Regents Of The University Of California Treatment to reduce edema
DE3942925A1 (de) * 1989-12-23 1991-06-27 Swf Auto Electric Gmbh Elektrischer schalter, insbesondere blinkerschalter fuer kraftfahrzeuge
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
US5480869A (en) * 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
US5245009A (en) * 1990-03-23 1993-09-14 The Salk Institute For Biological Studies CRF antagonists
US5374621A (en) * 1991-09-13 1994-12-20 Regents Of The University Of California Neurotensin method for inhibiting vascular leakage
US6495343B1 (en) 1993-06-18 2002-12-17 The Salk Institute For Biological Studies Cloning and recombinant production of CRF receptor(s)
US5728545A (en) * 1993-06-18 1998-03-17 The Salk Institute Of Biological Studies Cloning and recombinant production of CRF receptor (S)
US6638905B2 (en) 1993-06-18 2003-10-28 The Salk Institute For Biological Studies Cloning and recombinant production of CFR receptor(s)
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
CA2199734A1 (en) * 1994-09-12 1996-03-21 Fraser Aird Corticotropin release inhibiting factor and methods of using same
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7141546B1 (en) 2001-08-01 2006-11-28 The Salk Institute For Biologicial Studies CRFR2 selective ligands
AU2002355742A1 (en) * 2001-08-01 2003-02-17 The Salk Institute For Biological Studies Crfr1 selective ligands
US20090035298A1 (en) * 2007-04-23 2009-02-05 Washington University In St. Louis Methods to treat alzheimer's disease or other amyloid beta accumulation associated disorders
JP2011519375A (ja) * 2008-04-30 2011-07-07 ニュートロン ロウ 癌治療のためのコルチコトロピン放出因子の使用法
SG176802A1 (en) 2009-06-24 2012-01-30 Stephen Evans-Freke Methods of using corticotropin-releasing factor for the treatment of cancer
WO2012088397A2 (en) 2010-12-22 2012-06-28 The Salk Institute For Biological Studies Cyclic crf antagonist peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR67608E (fr) * 1955-02-22 1958-03-14 Variateur de vitesse, notamment pour cycles
GB2016015B (en) 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4415558A (en) 1981-06-08 1983-11-15 The Salk Institute For Biological Studies CRF And analogs
ATE72583T1 (de) 1981-11-23 1992-02-15 University Patents Inc Steuerung der dna-sequenzen-transkription.
GB2118190B (en) * 1982-04-13 1985-05-01 Erba Farmitalia Peptides with sauvagine-like activity

Also Published As

Publication number Publication date
DK172682B1 (da) 1999-05-25
IL71326A0 (en) 1984-06-29
DE3486238D1 (de) 1993-12-09
US4489163A (en) 1984-12-18
CA1247602A (en) 1988-12-28
GR81467B (es) 1984-12-11
IL71326A (en) 1987-11-30
EP0122798A2 (en) 1984-10-24
AU2677784A (en) 1984-10-18
KR900006559B1 (ko) 1990-09-13
IE61617B1 (en) 1994-11-16
PH23123A (en) 1989-05-05
AU565699B2 (en) 1987-09-24
DE3486238T2 (de) 1994-03-03
EP0122798A3 (en) 1986-09-03
JPS59199662A (ja) 1984-11-12
ES8606406A1 (es) 1986-04-01
NZ207779A (en) 1988-04-29
KR840009075A (ko) 1984-12-24
ZA842460B (en) 1984-11-28
ATE96807T1 (de) 1993-11-15
DK169784A (da) 1984-10-15
JPH0689034B2 (ja) 1994-11-09
EP0122798B1 (en) 1993-11-03
DK169784D0 (da) 1984-03-27
IE840867L (en) 1984-10-14

Similar Documents

Publication Publication Date Title
ES531585A0 (es) Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina
FI900726A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi
ES540632A0 (es) Un procedimiento de preparar peptidos.
DE69129985D1 (de) Crf-analoge

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050712